Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

Dare Bioscience (DARE) EPS (Basic) (2016 - 2025)

Historic EPS (Basic) for Dare Bioscience (DARE) over the last 10 years, with Q3 2025 value amounting to -$0.28.

  • Dare Bioscience's EPS (Basic) rose 4909.09% to -$0.28 in Q3 2025 from the same period last year, while for Sep 2025 it was -$1.88, marking a year-over-year decrease of 25471.7%. This contributed to the annual value of -$0.48 for FY2024, which is 8850.51% up from last year.
  • As of Q3 2025, Dare Bioscience's EPS (Basic) stood at -$0.28, which was up 4909.09% from -$0.45 recorded in Q2 2025.
  • Dare Bioscience's EPS (Basic)'s 5-year high stood at $1.53 during Q2 2024, with a 5-year trough of -$1.22 in Q2 2023.
  • In the last 5 years, Dare Bioscience's EPS (Basic) had a median value of -$0.28 in 2025 and averaged -$0.33.
  • Per our database at Business Quant, Dare Bioscience's EPS (Basic) crashed by 2698187.86% in 2023 and then soared by 22540.98% in 2024.
  • Over the past 5 years, Dare Bioscience's EPS (Basic) (Quarter) stood at -$0.18 in 2021, then dropped by 5.56% to -$0.19 in 2022, then tumbled by 268.42% to -$0.7 in 2023, then rose by 9.41% to -$0.63 in 2024, then skyrocketed by 55.84% to -$0.28 in 2025.
  • Its EPS (Basic) was -$0.28 in Q3 2025, compared to -$0.45 in Q2 2025 and -$0.5 in Q1 2025.